Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-25-003345
Filing Date
2025-08-04
Accepted
2025-08-04 16:15:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 15349
  Complete submission text file 0000902664-25-003345.txt   17375
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Subject) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91551 | Film No.: 251180453
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9 WEST 57TH STREET 29TH FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET 29TH FLOOR NEW YORK NY 10019 212-446-4000
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by) CIK: 0001595082 (see all company filings)

EIN.: 133863161 | State of Incorp.: DE
Type: SCHEDULE 13G/A